Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae

Eur J Clin Invest. 2000 Sep;30(9):818-22. doi: 10.1046/j.1365-2362.2000.00715.x.

Abstract

Background: All lipoproteins are able to bind to bacterial lipopolysaccharide (LPS), thereby neutralizing its deleterious effects. However, we demonstrated, recently, that in the absence of apolipoprotein E (apoE), eight-fold increased very-low-density lipoprotein levels were not sufficient to protect apoE-deficient (apoE-/-) mice against LPS. During a live Gram-negative infection, mechanisms other than LPS-neutralization may play a role in the pathogenesis of the disease. In the present study we further examined the role of apoE in Gram-negative sepsis.

Methods: Survival, bacterial outgrowth in liver, spleen, kidneys and blood, and tumour necrosis factor-alpha (TNF-alpha) production were measured in apoE-/- mice and control C57BL/6J mice, after an intravenous infection with Klebsiella pneumoniae.

Results: Mice that lack apoE showed higher mortality in response to K. pneumoniae than control mice (90% vs. 23% respectively after 2 weeks). ApoE-/- mice had 10-100 times more outgrowth of the bacteria in their organs than controls. Furthermore, circulating TNF-alpha concentrations 90 min after a challenge, were almost twice as high in the apoE-/- mice compared to controls (13.0 +/- 2.9 ng mL-1 vs. 7.6 +/- 3.8 ng mL-1). When apoE-/- and control mice were rendered neutropenic, the discrepancy in survival and outgrowth of K. pneumoniae disappeared.

Conclusions: The apoE-/- mice were more susceptible than control C57BL/6 mice to a K. pneumoniae infection. The absence of apoE may render these mice more susceptible, since this protein is of importance in the detoxification of lipopolysaccharide of Gram-negative bacteria. On the other hand, the phagocytic capacity of granulocytes seems to be decreased in apoE-/- mice, resulting in increased outgrowth and mortality.

MeSH terms

  • Animals
  • Apolipoproteins E / deficiency
  • Apolipoproteins E / metabolism*
  • Cholesterol / blood
  • Disease Models, Animal
  • Immunity
  • Klebsiella Infections / blood
  • Klebsiella Infections / immunology
  • Klebsiella Infections / microbiology*
  • Klebsiella Infections / mortality
  • Klebsiella pneumoniae / immunology*
  • Klebsiella pneumoniae / pathogenicity
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neutropenia / microbiology
  • Peptide Fragments / deficiency
  • Peptide Fragments / metabolism*
  • Triglycerides / blood

Substances

  • Apolipoproteins E
  • Peptide Fragments
  • Triglycerides
  • apolipoprotein E (141-155)
  • Cholesterol